Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coughlin Stoia Geller Rudman & Robbins LLP
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Medicis Pharmaceutical Corporation
November 2nd, 2008
Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the District of Arizona on behalf of purchasers of Medicis Pharmaceutical Corporation ("Medicis") (NYSE:MRX) securities during the period between October 30, 2003 and September 23, 2008 (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from October 3, 2008. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-02)
|
